Medical technology company Leo Cancer Care closed a $65 million series D financing round to scale its radiotherapy solution, which uses groundbreaking upright treatment technology.
Source: FierceBiotech
You may also like
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.